Custom Health IFRS net loss widens to US$33.4 million in FY26 Q2; revenue climbs 70% to US$7.4 million

Reuters2026/08/17 22:07

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Custom Health posted Q2 revenue of US$7.4 million, up 70% year over year; IFRS net loss widened to US$33.4 million.
Loss was driven mainly by a one-time, largely non-cash US$22.4 million IFRS 2 listing expense tied to the reverse takeover.
Gross profit rose 43% to US$2.9 million; gross margin fell 7.4 percentage points to 39.3%.
Non-IFRS adjusted EBITDA loss widened to US$3.3 million; adjusted EBITDA margin improved to -44.4% from -70%.
Signed deals for Evergreen Pharmacy, expected to add over US$78 million annual revenue, and Spencer Health; targets over US$130 million run-rate by end-2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Custom Health Holdings Inc. published the original content used to generate this news brief via Newsfile (Ref. ID: 202608171807NEWSFILECNPR____20260817_310104_1) on August 17, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Custom Health IFRS net loss widens to US$33.4 million in FY26 Q2; revenue climbs 70% to US$7.4 million

You may also like

Crypto prices